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Abstract 
Background: In the last two decades, there has been a significant increase in the diagnosis of Bipolar Disorder (BD) 
in children. The notion of prepubertal onsets of BD is not without controversy, with researchers debating whether 
paediatric cases have a distinct symptom profile or follow a different illness trajectory from other forms of BD. The 
latter issue is difficult to address without long‑term prospective follow‑up studies. However, in the interim, it is useful 
to consider the phenomenology observed in groups of cases with different ages of onset and particularly to compare 
manic symptoms in children diagnosed with BD compared to cases presenting with BD in adolescence and adult‑
hood. This review systematically explores the phenomenology of manic or hypomanic episodes in groups defined by 
age at onset of BD (children, adolescents and adults; or combined age groups e.g. children and adolescents versus 
adults).
Methods: Literature reviews of PubMed and Scopus were conducted to identify publications which directly com‑
pared the frequency or severity of manic symptoms in individuals with BD presenting with a first episode of mania in 
childhood, adolescence or adulthood.
Results: Of 304 studies identified, 55 texts warranted detailed review, but only nine studies met eligibility criteria for 
inclusion. Comparison of manic symptoms across age groups suggested that irritability is a key feature of BD with an 
onset in childhood, activity is the most prominent in adolescent‑onset BD and pressure of speech is more characteris‑
tic of adult‑onset BD. However, none of the eligible studies made a direct comparison of phenomenology in children 
versus adults. Assessment procedures varied in quality and undermined the reliability of cross‑study comparisons. 
Other limitations were: the scarcity of comparative studies, the geographic bias (most studies originated in the USA), 
the failure to fully consider the impact of psychiatric comorbidities on recorded symptoms and methodological 
heterogeneity.
Conclusions: Despite frequent discussion of similarities and differences in phenomenology of mania presenting 
in different age groups, systematic research is lacking and studies are still required to reliably establish whether the 
frequency and severity of manic symptoms varies. Such information has implications for clinical practice and the clas‑
sification of mental disorders.
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Background
Bipolar Disorder (BD) is a severe mental disorder that 
involves changes in mood, cognition and behaviour. It 
can be divided into three broad subgroups: BD-I (char-
acterized by episodes of mania and depression); BD-II 
(hypomania and depression) and a heterogeneous group 
that is sometimes referred to as ‘spectrum disorders’, 
which includes BD-NOS (Not Otherwise Specified), 
cyclothymia, and other less well-defined BD-like syn-
dromes (Akiskal et al. 2000; American Psychiatric Asso-
ciation (APA) 2000, 2013). The worldwide prevalence 
of all manifestations of BD is about 4% (Angst 1988). 
The peak age of onset is 15–25 years, but the incidence 
remains quite high throughout early and mid-adult life 
(Merikangas et  al. 2011). It is suggested that cases with 
adolescent or adult onset typically present with simi-
lar symptom profiles for each phase of the disorder e.g. 
manic, hypomanic, depressive and mixed episodes 
(where depressive and manic symptoms occur simultane-
ously), and that the frequency of different types of epi-
sodes are also comparable (e.g. depressive episodes are 
common; mixed states are relatively rare) (Angst 1988). 
There have been some variations reported in these char-
acteristics by age of onset, but overall cases presenting in 
adolescence or adulthood are usually regarded as having 
‘adult-pattern’ BD with distinct episodes (Carlson 2011; 
Merikangas et al. 2011; Douglas and Scott 2014).
In the last two decades, there has been a significant 
increase in the diagnosis of BD in childhood, the so-
called paediatric or juvenile-onset form of BD (Moreno 
et  al. 2007). The notion of prepubertal onsets of BD is 
not universally accepted, with researchers debating eve-
rything from whether the condition exists in this age 
group (or if it is a misdiagnosis of other childhood con-
ditions such as Attention Deficit Hyperactivity Dis-
order (ADHD)) and, if it does exist, how common it is, 
etc. (Douglas and Scott 2014; James et al. 2014). Whilst 
researchers and clinicians do not deny that children diag-
nosed with paediatric BD have psychological problems 
that need care and treatment, there is no consensus on 
whether this childhood condition is the same disorder 
as ‘adult-pattern’ BD that typically presents from ado-
lescence onwards (Carlson and Klein 2014; Wozniak 
et  al. 2010; Serra et  al. 2016). One issue that has fueled 
this debate is the lack of consensus on the core symp-
toms of hypomania or mania [which we will refer to as 
(hypo)mania] presenting in children. For example, sev-
eral researchers suggest that the juvenile form of BD is 
more likely to present with irritability rather than elation 
in mania, that mixed states may be more common, and/
or that there are differences in the frequency or severity 
of BD symptoms observed in prepubertal children com-
pared to other age groups (Findling et  al. 2001; Leiben-
luft et al. 2003; Geller et al. 2004; Youngstrom et al. 2008). 
This is an interesting and important idea but, many of the 
publications rely on reports of the frequency of specific 
(hypo)manic symptoms in samples comprised children 
only, rather than considering studies that directly com-
pare the symptoms of (hypo)manic episodes across age 
groups. Furthermore, studies of phenomenology often 
use different approaches to measuring the symptoms. For 
example, some studies report the presence or absence 
of the specific symptoms listed in internationally agreed 
diagnostic criteria (such as the A and B criteria reported 
in the Diagnostic and Statistical Manual (DSM IV); APA, 
2000). In contrast, other studies use symptom rating 
scales (such as the Young Mania Rating Scale; YMRS; 
Young et al. 1978), which assess the severity of any symp-
toms that are present (and report the mean severity score 
for each item on the rating scale). Lastly, some studies of 
children use information obtained from interviews with 
a parent (and/or a teacher), whilst studies of adolescents 
and adults usually primarily rely on information obtained 
from interviews with the index case (the person with BD) 
(Douglas and Scott 2014).
The primary purpose of this review is to explore sys-
tematically whether the clinical phenomenology of 
(hypo)mania differs across three age groups (children, 
adolescents and adults) or across younger versus older 
age groups (e.g. a combined group of children and ado-
lescents compared to adults with BD). The specific 
research questions are:
1. Is there a difference in the most frequently reported 
symptoms of (hypo)mania in different age groups in 
comparative studies that use recognized diagnostic 
criteria, e.g. DSM (American Psychiatric Association 
1980, 2000) or ICD (International Classification of 
Diseases; World Health Organization 1992), or that 
employ scales that measure the core symptoms of 
BD, e.g. Kiddie-Schedule for Affective Disorders and 
Schizophrenia (K-SADS; Endicott and Spitzer 1978)?
2. Is there a difference in which symptoms of (hypo)
mania are rated as the most severe in different age 
groups in comparative studies that used established 
symptom-rating scales, e.g. the YMRS?
Keywords: Systematic review, Mania, Phenomenology, Children, Adolescents, Adults, Manic symptoms, Irritability, 
Activity, Cognition
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Methods
To answer the key research questions, we identified pub-
lications that made a direct comparison of the symptoms 
of (hypo)mania in individuals with childhood, adolescent 
and/or adult-onset BD.
Search strategy
A systematic search of two online databases (Scopus and 
PubMed) was undertaken to identify any potentially rel-
evant peer-reviewed original articles, abstracts or confer-
ence proceedings. Citation lists of publications were also 
searched for additional publications. The time frame for 
the search was limited from January 1st 1980 until Sep-
tember 30th 2016. The start date was chosen because this 
was the first time the diagnosis of BD was included by the 
DSM classification system (DSM III; American Psychiat-
ric Association 1980). The search used combinations of 
terms from three broad categories (see “Appendix” for 
details): group 1 used various terms for BD (e.g. manic 
depress*); group 2 included terms for age groups (e.g. 
juven*); and group 3 focused on terms used to describe 
manic or hypomanic symptoms (e.g. psychopathol*).
The preliminary search was conducted by FR with con-
sultations held with JS (e.g. if clarification was required 
regarding the eligibility of a study). The initial searches 
identified 1658 titles, of which 304 abstracts that were 
potentially relevant (see the flow chart provided in Fig. 1). 
Examination of abstracts identified that 55 full text publi-
cations warranted detailed examination.
Eligibility criteria
The selected full text publications were assessed using the 
following eligibility criteria:
Inclusion criteria:
(a) Some or all study participants had a diagnosis of 
BD, and the data on BD cases were reported sepa-
rately.
(b) The study reported a comparison of symptoms 
between at least two groups defined by age of onset 
and at least one of these groups comprised children, 
adolescents or adults only.
(c) The symptoms were reliably recorded using either 
recognized diagnostic criteria (assessed by clinical 
interview, case note review or a researcher using 
a diagnostic interview schedule) or an established 
symptom rating scale (e.g. K-SADS Mania Rating 
Scale (K-MRS); Kaufman et al. 1997).
Exclusion criteria:
(a) Studies where age at onset or age ranges included in 
any group were unclear.
(b) Studies that reported data for only one gender 
group (e.g. the sample was 100% male).
(c) Studies that did not report the raw data for the rat-
ings of individual symptoms that were included in 
any group comparisons that were reported (e.g. 
some studies reported the items included in a fac-
tor analysis, but did not provide the mean scores for 
each item), or the information on symptom ratings 
could not be obtained from elsewhere (e.g. another 
publication from the same dataset or direct from 
the authors).
(d) Studies where symptoms were rated using idiosyn-
cratic rating scales of unknown or uncertain reli-
ability or validity, and/or the scales employed have 
not been used in any other studies of BD.
(e) Duplicate publications or additional publications 
from the same original dataset.
(f ) Studies that were not written in English, French, 
Spanish or German.
Data extraction and coding
The review was carried out following the Preferred 
Reporting Items for Systematic Reviews and Meta-Analy-
ses (PRISMA) guidelines (Moher et al. 2009).
For studies meeting eligibility criteria, information was 
extracted on: number of participants, country and year 
of study, clinical setting, gender distribution, age groups 
examined and BD subtypes included (see Table  1). The 
quality of eligible studies was assessed using the Criti-
cal Appraisal Skills Programme Checklist for systematic 
reviews (CASP 2013), which considers a range of key cri-
teria including population studied (sample size and rep-
resentativeness), methodology and standard of reporting 
of statistical analysis.
Data from each eligible study were reviewed, and each 
publication was categorized by the age groups included. 
Three sub-sets were identified:
  • studies that reported the proportion of the sample 
with one or more of the diagnostic symptoms of 
(hypo)mania;
  • studies that reported the proportion of cases with 
symptoms assessed using a diagnostic interview 
schedule;
  • studies that reported the mean scores for each symp-
tom on a severity rating scale, or used another rec-
ognized approach to reporting the severity of symp-
toms, e.g. the percent of maximum possible item 
score (POMP).
Data synthesis
FR identified the six most frequent (or for all the symp-
toms reported, if less than six were examined) or the 
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six most severe symptoms reported in each age group 
included in each study. The symptom descriptions and 
rankings (as summarized in Tables 2 and 3) are described 
using the specific item descriptions provided in the origi-
nal assessment scale and the frequency or severity data 
were as reported by the original researchers.
The symptoms as described were then put in rank order 
(with the most common or severe symptom ranked first) 
and tabulated. (It is important to note that the authors 
did not make any modification to the reported symptoms 
or items at this stage and, for example, as the construct 
grandiose/bizarre thought content is reported as a single 
symptom in the assessments reported in several studies, 
we retained that descriptor of presenting phenomenol-
ogy in our review). If two or more items in an assessment 
scale occurred at the same frequency or had the same 
mean level of severity, we report both items (as they have 
an equal ranking). Any uncertainties on how to interpret 
the description or ranking of a symptom reported in the 
original data paper were resolved by consensus (JS and 
FR).
Having examined the reporting of the frequency and 
severity of symptoms as reported in eligible studies, it 
was noted that the studies showed heterogeneity in the 
assessment tools used, and most methodologies were 
rated as modest or lower quality. Also, there were only 
a small number of relevant publications available, espe-
cially for comparisons of severity of symptoms. As such, 
it was clear that it was not appropriate to use meta-
analytic or other statistical approaches to the pooled 
data, and so we decided to use a simple strategy to give 
an insight into the distribution of manic symptoms in 
4 
Records after removal 




Records screened  
(n = 304) 
Full text articles 
assessed for eligibility  
(n = 55) 
Records excluded  
(n = 249) 
Full text articles excluded 
(n = 46) 
 Reasons: 
- Did not report severity 
scores for individual 
symptom by age groups 
(e.g. factor analysis) 
- Did not use established 
rating tool or did not report 
symptoms using 
established terminology 
- Included diagnoses other 
than BD 
- Duplicate dataset 
Number of independent 
datasets included in systematic 
review 
(n = 9) 
Publications identified 
through database searching  
(n = 4042) 
Publications identified 
through reference lists  
(n = 127) 
Fig. 1 Study flow chart
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different age groups based on the rankings obtained for 
frequency and severity. First, we allocated each rank a 
numerical score (1st rank =  6; 2nd rank =  5, etc.). The 
total score for each manic symptom was calculated (as a 
composite of the ranking scores of frequency and sever-
ity for all studies), and the symptoms were then arranged 
in the descending order (using this score). We selected 
the ten highest scoring items and examined the descrip-
tion of each item to establish if there were duplications 
in regards to overlapping or similar symptoms in the 
list (e.g. some scales separate activity and energy, some 
combine them in a single item, etc.). Similar or overlap-
ping symptoms were grouped into single items (e.g. irri-
tability and aggression were collapsed into a single item; 
activity and energy were collapsed into a single item), 
and the ranking scores were adjusted accordingly. This 
strategy produced a final list of the five most common 
manic symptoms reported across studies. We then exam-
ined the ranking scores for each symptom by age group 
(expressing this as a weighted  %). It is emphasised that 
results offer a graphical representation of symptom dis-
tributions by age group (we did not apply statistical sig-
nificance tests as this was deemed inappropriate). Our 
goal is simply to establish which symptoms are more 
prominent (in terms of frequency and/or severity) in 
each age group compared to the total sample included in 
the review.
Results
As noted in Fig. 1, nine studies met eligibility criteria for 
inclusion in the review. The CASP assessment revealed 
that three studies achieved good-to-high-quality ratings 
(Findling et  al. 2001; Birmaher et  al. 2009; Chan et  al. 
2011), three were rated as good-to-modest (McElroy 
et  al. 1997; Lazaro et  al. 2007; Safer et  al. 2012), whilst 
three studies achieved lower scores, suggesting some 
methodological weaknesses (Ballenger et al. 1982; Jerrell 
and Shugart 2004; Song et al. 2010).
As shown in Table  1, the studies were published over 
a 30-year period. Six of the nine studies were from the 
USA. Sample sizes ranged from 21 to 1106; in five stud-
ies, most of the participants were male. Three studies 
reported data from inpatients only and three from out-
patients only. Five studies focused on BD-I cases, and the 
remaining studies included mixed samples of BD-I, BD-II 
and BD-NOS cases.
Table 1 Sample characteristics for eligible publications (listed by year of publication)
NK not known
a Age Groups: child refers to prepubertal children or those aged ≤12; adolescent refers to age ≥13 to 18 years, although one study extended the age range up to 
21 years; –adult refers to individuals aged ≥18 years, although one study chose a minimum of age ≥30 years
b Percentages are reported to the nearest integer
c The study reported three age groups, but only two met eligibility criteria for inclusion in this review
Publication Country Sample size (n) Gender (% 
males)b
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Fifty-six percent of the studies (5 out of 9) compared 
the symptoms of (hypo)mania in children versus adoles-
cents (Findling et  al. 2001; Lazaro et  al. 2007; Birmaher 
et al. 2009; Song et al. 2010; Chan et al. 2011). Two stud-
ies combined children and adolescents into one group 
(minimum age 7 years; maximum age 17 years) and com-
pared the younger group with adults (Jerrell and Shugart 
2004; Safer et al. 2012). The other two studies compared 
groups of adolescents (maximum age ranged from 18 
to 21  years) to adults (minimum age varied from 19 to 
30 years) (Ballenger et al. 1982; McElroy et al. 1997).
Tables  2 and 3 report the findings regarding the rank 
order of symptoms based on the frequency or severity 
rating of each item. Four of seven studies identified irri-
tability or irritability and aggression as the highest rank-
ing symptom in the youngest age group assessed (either 
children alone or a group comprising children and ado-
lescents). The two highest ranking symptoms in the seven 
studies that included an adolescent group were increased 
activity/energy, closely followed by elated/euphoric mood 
(Ballenger et al. 1982; McElroy et al. 1997; Findling et al. 
2001; Lazaro et al. 2007; Birmaher et al. 2009; Song et al. 
2010; Chan et al. 2011). One study (Ballenger et al. 1982) 
compared adolescents and adults and found that gran-
diosity was more common in the adolescent group and 
pressured speech was ranked highest in the adult group; 
decreased sleep was a frequent symptom for both age 
groups. McElroy et al. (1997) also compared adolescents 
with adults; the study reported that increased motor 
activity was the highest ranking symptom in the former 
compared to bizarre/grandiose thought content in the 
latter; psychotic symptoms (namely delusions) were the 
second most severe symptom reported in both groups.
Figure  2 shows the data on symptom distributions 
(using a composite ranking of frequency and sever-
ity) reported as weighted percentages by age groups. 
As shown, there are some variations in symptom pat-
terns by age, with irritability/aggression being the most 
prominent feature of childhood BD and activity/energy is 
the most prominent in adolescent BD; the second most 
prominent symptom is both these age groups is elated/
euphoric mood. In adult BD, the two most prominent 
symptoms are those associated with changes in cogni-
tion (namely speed of thinking as described by pressure 
of speech and racing thoughts; and content of thinking as 
described by grandiose or bizarre ideas).
Discussion
The aim of this systematic review was to explore whether 
there are any differences in the phenomenology of (hypo)
manic episodes reported in studies that compare symp-
toms across groups with different ages of onset. As we 
examined both the frequency and severity of symptoms, 
this approach also offered some insights into whether the 
instruments used to measure the symptoms influence the 
patterns of symptoms observed. Before discussing our 
Table 3 Rank order of severity of manic symptoms by age group (symptoms are reported as mean score or  %)
N.B. The range of possible scores for YMRS and K-MRS items differ, so mean scores are not directly comparable for similar symptoms
a  Young Mania Rating Scale (YMRS); b K-SADS Mania Rating Scale (K-MRS)
c  Most items are from the YMRS, but ‘delusions’ and ‘bizarre/grandiose thought content’ were from the Scale for Assessment of Positive Symptoms
d  POMP = Percent of maximum possible score; All  % are reported to the nearest integer
McElroy et al. (1997)a Birmaher et al. (2009)b,c Safer et al. (2012)a
Mean ± SD Mean ± SD POMPd (%)
Adolescent Adult Child Adolescent Child/adolescent Adult
Increased motor activity




High energy (4.3 ± 1.4) High energy (4.8 ± 1.0) Irritability (17) Grandiosity (16)
Delusions
  (2.1 ± 1.7)
Delusions (2.7 ± 1.4) Increased motor activity 
(4.3 ± 1.2)
Decreased need for sleep 
(4.5 ± 1.7)
Aggression (15) Rapid speech (16)
Bizarre/grandiose 
thought content
  (2.1 ± 1.9)
Thought disturbance 
(2.2 ± 1.6)
Irritability (4.1 ± 1.5) Elation (4.4 ± 1.0) Rapid speech (15) Irritability (14)
Thought disturbance
  (1.4 ± 1.6)
Sleep disturbance 
(1.9 ± 1.2)
Mood lability (4.1 ± 1.1) Increased motor activity 
(4.3 ± 1.1)
Grandiosity (10) Motor activity (10)
Sleep disturbance
  (1.3 ± 1.3)
Increased motor activity 
(1.8 ± 1.4)
Elation (3.9 ± 1.2) Accelerated speech 
(4.2 ± 1.1)
Motor activation (9) Elevated mood (9)
Increased goal directed/
aggressive behaviour










Elevated mood (9) Aggression (9)
Page 8 of 11Ryles et al. Int J Bipolar Disord  (2017) 5:4 
findings, it is important to note that there were limita-
tions in achieving these aims of this review. Firstly, the 
studies defined the boundaries of three age groups in dif-
ferent ways. For instance, Ballenger et al. (1982) consid-
ered adolescence to extend to the age of 21, whereas most 
of the other studies used an upper age limit of 18. Sec-
ondly, the relative lack of eligible studies and the different 
compositions (some combining children and adolescents) 
and sizes of the age groups meant that we were only able 
to obtain data on about 2000 cases (268 children, a com-
bined subsample of 540 children and adolescents, 265 
adolescents and 933 adults). The limited number of cases 
per age group in the reviewed studies is further compli-
cated by the heterogeneity in the range of BD subtypes 
included and timing of assessment of symptoms. Also, 
none of the eligible studies used the revised criteria for 
the diagnosis of BD as written in the DSM-5, which now 
incorporate activity and energy alongside mood change 
as the criterion A symptom for (hypo)mania (APA 2013). 
Thirdly, six studies were conducted in the USA, where 
approaches towards the diagnosis of BD in children has 
tended to differ from some, but not all, other parts of 
the world (Dubicka et al. 2008; Douglas and Scott 2014; 
James et  al. 2014). Most importantly, despite the level 
of interest expressed in the phenomenology of BD and 
whether it is different in children, very few studies exist 
that directly compare the symptoms of paediatric BD 
with adolescent-onset or adult-onset BD; and even fewer 
studies use samples recruited in the same location and/or 
at the same time. These issues are relevant as diagnostic 
procedures and practices show both geographic and tem-
poral trends (Mackin et al. 2006; Moreno et al. 2007).
The most significant finding of this review is that 
only nine publications met eligibility criteria for inclu-
sion, and these studies used a range of methodologies 
and approaches to symptom assessment. Some relied 
on reviews of case notes and, even if this retrospec-
tive reporting of data was reliable, some of the studies 
were hampered by focusing on relatively few symptoms 
of mania [e.g. Lazaro et  al. (2007) only examined three 
symptoms]. Others included ratings of additional symp-
toms of BD, such as depression (e.g. Song et  al. 2010), 
without specifying if these occurred within a manic 
episode (suggesting the possibility of mixed states) or 
outside the manic phase. Also, studies of the frequency 
of manic symptoms often used different tools, some of 
which did not even include symptoms that are deemed 
core features of mania. Of those studies relying on sever-
ity scores, the use of different rating scales (e.g. the YMRS 
and K-MRS), made cross-study comparisons difficult, as 
the scales do not include identical sets of symptoms, or 
they give different weightings to the same manic symp-
toms. For instance, irritability in the YMRS (Young et al. 
1978) is rated 0–8, whilst most other symptoms are rated 
0–4. However, on the K-MRS (Kaufman et  al. 1997), all 
but one item are rated 1–6 (distractibility is rated 1–5). 
Furthermore, some scales use composite ratings for 
activity and energy or for irritability and aggression, 
grandiose/bizarre thinking, etc. As such, it is likely that 
the different approaches to assessment by the original 
Fig. 2 Schematic representation of symptom patterns across age groups (based on a weighting of derived from the frequency and severity of each 
symptom)
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researchers have influenced the findings of this review. 
We tried to overcome some of these problems using 
rank-ordering the phenomena, but it is emphasized that 
most findings from the synthesis of pooled data must be 
treated with caution.
It was notable that none of the studies in this review 
directly compared a ‘child only’ group to an ‘adult only’ 
group. This is surprising, given the debate about the simi-
larities or differences in symptoms profiles and nature of 
BD in these two age groups. Safer et al. (2012) and Jerrell 
and Shugart (2004) compared a group comprised chil-
dren and adolescents with an adult group. Their findings 
suggest irritability is more prominent in the younger age 
group compared to the adults. Both studies included in- 
and out-patients, which may indicate that cases were at 
a more severe end of the spectrum than in some other 
studies; however, Safer et  al. (2012) did not recruit all 
the participants at the same time, and the cases in each 
group were not assessed by the same clinicians, which 
introduces potential sources of bias.
The pattern of manic symptoms in children compared 
to adolescents varied across studies and by assessment 
procedure. Figure  2 identifies that irritability/aggres-
sion was more prominent in children diagnosed with 
BD compared to adolescents, which offers some sup-
port to previous findings which suggest that irritability 
is frequent and severe in paediatric and juvenile BD (e.g. 
Tillman and Geller 2007; Soutullo et al. 2009). A recent 
meta-analysis of 20 studies (Van Meter et al. 2016) sug-
gested that irritability was the second most prevalent 
symptom of mania (77%) in childhood (interestingly, that 
meta-analysis found that increased energy was the most 
common symptom). However, Van Meter et  al. (2016) 
took a different approach to study selection than used in 
the current review, and assessed symptom distribution 
within paediatric BD using a wider range of studies, most 
of which did not compare the distribution of symptoms 
across childhood-, adolescent and adult-onset groups. As 
such, the reviews offer complementary rather than com-
peting views of the phenomenology of (hypo)mania in 
childhood-onset cases of BD.
Whilst the finding regarding irritability in younger age 
groups is of interest, it is important to note that irrita-
bility cannot be regarded as a specific indicator of bipo-
larity. For instance, periods of irritability can be part of 
normal development in young children and adolescents 
(Pataki and Carlson 2013), so irritability on its own may 
not indicate any underlying disease process. In contrast, 
persistent irritability or distractibility might be a feature 
of other mental disorders, such as ADHD, or of underly-
ing organic brain disease, rather than part of a manic syn-
drome (Vidal-Ribas et al. 2016). This is especially relevant 
to this review, as many studies of prepubertal BD in the 
literature suggest comorbidity rates with ADHD that 
exceed 50% (range 30–95%) (e.g. Faraone et al. 1997; Bie-
derman et  al. 1996; Bernardi et  al. 2010). Indeed, some 
reviews question whether it is possible to reliably differ-
entiate ADHD from BD in children, or whether ADHD 
may be misdiagnosed as BD [e.g. Skirrow et  al. (2012)]. 
We were not able to determine whether the symptom 
of irritability/aggression recorded in the studies in this 
review included only episodic phenomena or encom-
passed more chronic presentations. However, clarifica-
tion is needed, as Leibenluft et al. (2003) highlights that 
there is a degree of uncertainty about how to classify 
some of these cases and Meyer et  al. (2011) suggested 
that child psychiatrists should perhaps rely more on 
what are considered prototypical manic symptoms such 
as increased energy or decreased need for sleep when 
diagnosing BD in children. Interestingly, the DSM-5 now 
includes a separate category of Disruptive Mood Dys-
regulation Disorder, which is likely to lead to revisions in 
how some cases with presentations dominated by irrita-
bility being re-diagnosed.
Finally, whilst the primary focus of this review was 
to examine if comparative studies can shed light on the 
phenomenology of childhood-onset BD versus other age 
groups, the findings regarding the most prominent symp-
toms of adolescent and adult BD are also worthy of com-
ment. The identification of activity/energy as a primary 
symptom in these clinical studies of adolescents confirms 
previous reports by Merikangas et  al. (2011) derived 
from large-scale community-based cohort studies. To the 
best of our knowledge, the finding that cognitive symp-
toms (speed and content of thought) are more prominent 
in adults compared to younger age groups has not been 
reported previously. Whilst it is possible that this is an 
artefact of the weightings procedure used in this review 
to allow cross-study comparison of symptoms, the find-
ing is worth highlighting. Part of the explanation for cog-
nitive symptoms of mania being more marked in adults 
compared to children is that children may be less able 
to express their experiences or ideas verbally, the assess-
ment procedure may not have been sufficiently sensitive 
to detect some of the cognitive changes in children, or the 
symptoms may have been attributed to a comorbid con-
dition, etc. However, this explanation might not extend to 
the difference between adults and adolescents. As such, 
this (and our other findings on symptom patterns across 
age groups) warrant further research that applies more 
sophisticated approaches to the assessment of symptoms 
and their differential contribution to the presentation of 
(hypo)mania, such as item response theory (e.g. Wein-
stock et al. 2009).
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Conclusions
To the best of our knowledge, this is the first attempt to 
synthesize data from studies that directly compare symp-
toms of BD across groups defined by age. Irritability is a 
striking feature of mania in groups that include children 
(children only or children and adolescents) who were 
diagnosed with BD. However, given the debates regard-
ing the similarities or differences between adult-pattern 
and childhood onset BD, it is disappointing that no 
study makes a direct comparison of the phenomenology 
observed in children and adults. Other findings of note 
in this review are the sparsity of eligible high-quality 
studies, the lack of geographical spread in available stud-
ies (leading to a bias towards studies undertaken in the 
USA), the failure of studies of phenomenology to fully 
account for the impact of comorbidity on symptom rat-
ings and the methodological heterogeneity. Therefore, 
we conclude that systematic research on this topic is still 
required to answer important clinical questions about 
the presentation or evolution of (hypo)mania across dif-
ferent age groups, which is an issue that has implications 
not only for day-to-day practice, but also for research on 
the classification of mental disorders.
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